Compounds > pamidronate

pamidronate and paclitaxel

pamidronate has been researched along with paclitaxel in 11 studies

Research

Studies (11)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	6 (54.55)	29.6817
2010's	5 (45.45)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Lombardo, F; Obach, RS; Waters, NJ	1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ	1
Ekins, S; Williams, AJ; Xu, JJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Becker, AJ; Buttner, R; Rath, W; Rudlowski, C; Wiestler, OD	1
Haritoglou, C; Mueller, AJ	1
Ando, M; Rai, Y; Sagara, Y; Takahama, T	1
Nakahara, K; Ogino, T; Osanai, T; Tsuchiya, T	1
Chang, KC; Eun, SY; Hong, SC; Kang, ES; Kim, HJ; Kim, JH; Lee, JH; Seo, HG; Woo, IS	1
Armaiz-Pena, GN; Arumugam, T; Aslan, B; Cohen, E; Cruz-Monserrate, Z; Del C Monroig-Bosque, P; Deng, D; Erdogan, MA; Fuentes-Mattei, E; Gao, H; Garza, RJ; Gonzalez-Villasana, V; Gutierrez-Puente, Y; Hwang, RF; Ivan, C; Logsdon, C; Lopez-Berestein, G; Ozpolat, B; Philip, B; Rashed, MH; Reuben, JM; Rodriguez-Aguayo, C; Sood, AK; Wang, H	1

Reviews

1 review(s) available for pamidronate and paclitaxel

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

10 other study(ies) available for pamidronate and paclitaxel

Article	Year
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Developing structure-activity relationships for the prediction of hepatotoxicity. Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
Trastuzumab and breast cancer. The New England journal of medicine, 2001, Sep-27, Volume: 345, Issue:13 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms, Male; Diphosphonates; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Pamidronate; Receptor, ErbB-2; Trastuzumab	2001
[Regression of an uveal metastatic tumor from breast cancer during chemotherapy--a case report]. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2003, Volume: 100, Issue:4 Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Choroid Neoplasms; Combined Modality Therapy; Diphosphonates; Docetaxel; Doxorubicin; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Paclitaxel; Pamidronate; Tamoxifen; Taxoids; Time Factors; Ultrasonography; Visual Acuity	2003
[Effective weekly paclitaxel therapy for massive metastatic breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2004, Volume: 31, Issue:5 Topics: Adult; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Mastectomy, Radical; Paclitaxel; Pamidronate; Quality of Life	2004
Long-term prevention of skeletal complications by pamidronate in a patient with bone metastasis from endometrial carcinoma: a case report. Gynecologic oncology, 2006, Volume: 100, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Bone Neoplasms; Carboplatin; Diphosphonates; Endometrial Neoplasms; Epirubicin; Female; Humans; Paclitaxel; Pamidronate	2006
Farnesyl diphosphate synthase attenuates paclitaxel-induced apoptotic cell death in human glioblastoma U87MG cells. Neuroscience letters, 2010, Apr-26, Volume: 474, Issue:2 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Survival; Diphosphonates; Drug Synergism; Flow Cytometry; Geranyltranstransferase; Glioblastoma; Humans; JNK Mitogen-Activated Protein Kinases; Mevalonic Acid; Paclitaxel; Pamidronate; Polyisoprenyl Phosphates; Sesquiterpenes; Signal Transduction; Time Factors; Tumor Suppressor Protein p53	2010
Bisphosphonates inhibit stellate cell activity and enhance antitumor effects of nanoparticle albumin-bound paclitaxel in pancreatic ductal adenocarcinoma. Molecular cancer therapeutics, 2014, Volume: 13, Issue:11 Topics: Adult; Albumins; Animals; Apoptosis; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Diphosphonates; Drug Synergism; Female; Humans; Immunohistochemistry; Mice; Mice, Nude; Nanoparticles; Paclitaxel; Pamidronate; Pancreatic Neoplasms; Pancreatic Stellate Cells; Xenograft Model Antitumor Assays	2014